AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,501,683 | -40.8% | 437,056 | -5.2% | 0.00% | -100.0% |
| Q2 2023 | $7,598,840 | +140.0% | 461,094 | +33.4% | 0.00% | – |
| Q1 2023 | $3,166,714 | +27.3% | 345,711 | -0.5% | 0.00% | – |
| Q4 2022 | $2,486,811 | +43.1% | 347,320 | +0.1% | 0.00% | – |
| Q3 2022 | $1,738,000 | +125.1% | 346,852 | +9.6% | 0.00% | – |
| Q2 2022 | $772,000 | -67.1% | 316,361 | -7.8% | 0.00% | – |
| Q1 2022 | $2,343,000 | -36.6% | 343,009 | -25.0% | 0.00% | – |
| Q4 2021 | $3,694,000 | -11.1% | 457,264 | +7.8% | 0.00% | -100.0% |
| Q3 2021 | $4,157,000 | +64.1% | 424,220 | +12.7% | 0.00% | – |
| Q2 2021 | $2,533,000 | +25.0% | 376,265 | +67.9% | 0.00% | – |
| Q1 2021 | $2,026,000 | +39.0% | 224,079 | +2.6% | 0.00% | – |
| Q4 2020 | $1,458,000 | -13.0% | 218,305 | -34.3% | 0.00% | – |
| Q3 2020 | $1,676,000 | +45.1% | 332,466 | +132.6% | 0.00% | – |
| Q2 2020 | $1,155,000 | -12.1% | 142,916 | -13.7% | 0.00% | – |
| Q1 2020 | $1,314,000 | -76.1% | 165,588 | -77.3% | 0.00% | -100.0% |
| Q4 2019 | $5,507,000 | +78.7% | 729,289 | -1.5% | 0.00% | 0.0% |
| Q3 2019 | $3,081,000 | +48.5% | 740,496 | +3.1% | 0.00% | 0.0% |
| Q2 2019 | $2,075,000 | +102.2% | 717,901 | +0.7% | 0.00% | – |
| Q1 2019 | $1,026,000 | -44.9% | 712,658 | -1.3% | 0.00% | -100.0% |
| Q4 2018 | $1,863,000 | -45.4% | 722,019 | -7.1% | 0.00% | 0.0% |
| Q3 2018 | $3,412,000 | +15.4% | 777,272 | +61.2% | 0.00% | 0.0% |
| Q2 2018 | $2,956,000 | -64.2% | 482,236 | -57.4% | 0.00% | -50.0% |
| Q1 2018 | $8,248,000 | -35.6% | 1,131,337 | -27.5% | 0.00% | -50.0% |
| Q4 2017 | $12,798,000 | -18.9% | 1,560,739 | +3.9% | 0.00% | -20.0% |
| Q3 2017 | $15,776,000 | -9.0% | 1,502,426 | -4.4% | 0.01% | 0.0% |
| Q2 2017 | $17,334,000 | -30.7% | 1,571,497 | -39.2% | 0.01% | +25.0% |
| Q1 2017 | $25,022,000 | – | 2,584,892 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 985,210 | $10,345,000 | 6.10% |
| Broadfin Capital, LLC | 3,568,122 | $37,465,000 | 5.54% |
| JW Asset Management, LLC | 444,439 | $4,667,000 | 3.42% |
| ARMISTICE CAPITAL, LLC | 1,688,000 | $17,724,000 | 2.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $38,383,000 | 1.73% |
| FALCON POINT CAPITAL, LLC | 661,490 | $6,284,000 | 0.91% |
| KNOTT DAVID M | 158,555 | $1,665,000 | 0.71% |
| Perceptive Advisors | 3,098,010 | $32,530,000 | 0.62% |
| Sio Capital Management, LLC | 91,413 | $960,000 | 0.50% |
| HEARTLAND ADVISORS INC | 700,000 | $7,350,000 | 0.48% |